In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...

T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and ...

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according ...

MIT and Harvard scientists have created engineered CAR-NK cells that can hide from the immune system and more effectively ...

Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For ...

CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Early research has identified several antigens that could ...

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

The Nobel Prize in Medicine was awarded on Monday to three scientists for discovering how a particular kind of cell can stop ...

CAR-T cell therapy has cured some children with blood cancers and is being studied in solid tumors, where responses differ ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...

A research team at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has discovered that certain dietary fatty acids can supercharge the human immune system's ability to fight cancer ...